nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—Coordination disturbance—Hydrochlorothiazide—nephrolithiasis	0.11	0.149	CcSEcCtD
Carbamazepine—Reflexes abnormal—Hydrochlorothiazide—nephrolithiasis	0.0951	0.129	CcSEcCtD
Carbamazepine—Conduction disorder—Hydrochlorothiazide—nephrolithiasis	0.0378	0.0514	CcSEcCtD
Carbamazepine—CYP2C19—urine—nephrolithiasis	0.0193	0.0788	CbGeAlD
Carbamazepine—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.018	0.0245	CcSEcCtD
Carbamazepine—CYP1A2—urine—nephrolithiasis	0.0157	0.0644	CbGeAlD
Carbamazepine—Epigastric discomfort—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0205	CcSEcCtD
Carbamazepine—CYP2C9—urine—nephrolithiasis	0.0149	0.0611	CbGeAlD
Carbamazepine—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0192	CcSEcCtD
Carbamazepine—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0159	CcSEcCtD
Carbamazepine—SCN9A—nephron tubule—nephrolithiasis	0.0116	0.0476	CbGeAlD
Carbamazepine—CYP3A4—urine—nephrolithiasis	0.0114	0.0466	CbGeAlD
Carbamazepine—RALBP1—nephron tubule—nephrolithiasis	0.0113	0.046	CbGeAlD
Carbamazepine—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0141	CcSEcCtD
Carbamazepine—RALBP1—renal system—nephrolithiasis	0.0102	0.0418	CbGeAlD
Carbamazepine—UGT2B7—renal system—nephrolithiasis	0.0102	0.0418	CbGeAlD
Carbamazepine—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0137	CcSEcCtD
Carbamazepine—RALBP1—kidney—nephrolithiasis	0.00989	0.0405	CbGeAlD
Carbamazepine—UGT2B7—kidney—nephrolithiasis	0.00989	0.0405	CbGeAlD
Carbamazepine—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.00988	0.0404	CbGeAlD
Carbamazepine—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00978	0.0133	CcSEcCtD
Carbamazepine—RALBP1—cortex of kidney—nephrolithiasis	0.00964	0.0394	CbGeAlD
Carbamazepine—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00963	0.0131	CcSEcCtD
Carbamazepine—SCN4A—renal system—nephrolithiasis	0.00944	0.0386	CbGeAlD
Carbamazepine—SCN4A—kidney—nephrolithiasis	0.00912	0.0373	CbGeAlD
Carbamazepine—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00845	0.0346	CbGeAlD
Carbamazepine—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00812	0.011	CcSEcCtD
Carbamazepine—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00807	0.011	CcSEcCtD
Carbamazepine—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00748	0.0102	CcSEcCtD
Carbamazepine—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00744	0.0101	CcSEcCtD
Carbamazepine—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00705	0.00958	CcSEcCtD
Carbamazepine—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00655	0.0089	CcSEcCtD
Carbamazepine—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00655	0.0089	CcSEcCtD
Carbamazepine—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00652	0.00886	CcSEcCtD
Carbamazepine—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00643	0.00874	CcSEcCtD
Carbamazepine—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00637	0.00866	CcSEcCtD
Carbamazepine—Injury—Hydrochlorothiazide—nephrolithiasis	0.00626	0.0085	CcSEcCtD
Carbamazepine—Cyproheptadine—CHRM3—nephrolithiasis	0.00615	0.314	CrCbGaD
Carbamazepine—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00609	0.00828	CcSEcCtD
Carbamazepine—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00604	0.00821	CcSEcCtD
Carbamazepine—ABCC2—nephron tubule—nephrolithiasis	0.00604	0.0247	CbGeAlD
Carbamazepine—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00597	0.00811	CcSEcCtD
Carbamazepine—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00577	0.00785	CcSEcCtD
Carbamazepine—ABCC2—renal system—nephrolithiasis	0.00549	0.0224	CbGeAlD
Carbamazepine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00541	0.00735	CcSEcCtD
Carbamazepine—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00531	0.00722	CcSEcCtD
Carbamazepine—ABCC2—kidney—nephrolithiasis	0.00531	0.0217	CbGeAlD
Carbamazepine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00525	0.00714	CcSEcCtD
Carbamazepine—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00523	0.00711	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00518	0.00704	CcSEcCtD
Carbamazepine—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00518	0.00704	CcSEcCtD
Carbamazepine—ABCC2—cortex of kidney—nephrolithiasis	0.00517	0.0211	CbGeAlD
Carbamazepine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00689	CcSEcCtD
Carbamazepine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00497	0.00675	CcSEcCtD
Carbamazepine—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00487	0.00662	CcSEcCtD
Carbamazepine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00459	0.00624	CcSEcCtD
Carbamazepine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00458	0.00622	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00454	0.00617	CcSEcCtD
Carbamazepine—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00615	CcSEcCtD
Carbamazepine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00448	0.00609	CcSEcCtD
Carbamazepine—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00446	0.00606	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00597	CcSEcCtD
Carbamazepine—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00436	0.00592	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00434	0.0059	CcSEcCtD
Carbamazepine—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00587	CcSEcCtD
Carbamazepine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00585	CcSEcCtD
Carbamazepine—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00585	CcSEcCtD
Carbamazepine—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00423	0.00574	CcSEcCtD
Carbamazepine—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00565	CcSEcCtD
Carbamazepine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00414	0.00562	CcSEcCtD
Carbamazepine—CYP2C8—renal system—nephrolithiasis	0.00412	0.0168	CbGeAlD
Carbamazepine—CYP3A5—nephron tubule—nephrolithiasis	0.00409	0.0167	CbGeAlD
Carbamazepine—CYP2B6—nephron tubule—nephrolithiasis	0.00406	0.0166	CbGeAlD
Carbamazepine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00405	0.0055	CcSEcCtD
Carbamazepine—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00399	0.00542	CcSEcCtD
Carbamazepine—CYP2C8—kidney—nephrolithiasis	0.00398	0.0163	CbGeAlD
Carbamazepine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00398	0.00541	CcSEcCtD
Carbamazepine—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00395	0.00537	CcSEcCtD
Carbamazepine—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00533	CcSEcCtD
Carbamazepine—CYP1A2—renal system—nephrolithiasis	0.00385	0.0158	CbGeAlD
Carbamazepine—Promethazine—CHRM3—nephrolithiasis	0.00378	0.193	CrCbGaD
Carbamazepine—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00511	CcSEcCtD
Carbamazepine—CYP3A5—renal system—nephrolithiasis	0.00372	0.0152	CbGeAlD
Carbamazepine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00371	0.00504	CcSEcCtD
Carbamazepine—CYP2B6—renal system—nephrolithiasis	0.00369	0.0151	CbGeAlD
Carbamazepine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00369	0.00502	CcSEcCtD
Carbamazepine—CYP3A5—kidney—nephrolithiasis	0.00359	0.0147	CbGeAlD
Carbamazepine—CYP2B6—kidney—nephrolithiasis	0.00357	0.0146	CbGeAlD
Carbamazepine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00483	CcSEcCtD
Carbamazepine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00352	0.00478	CcSEcCtD
Carbamazepine—CYP3A5—cortex of kidney—nephrolithiasis	0.0035	0.0143	CbGeAlD
Carbamazepine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00471	CcSEcCtD
Carbamazepine—Desipramine—CHRM3—nephrolithiasis	0.00343	0.175	CrCbGaD
Carbamazepine—Tension—Hydrochlorothiazide—nephrolithiasis	0.0034	0.00462	CcSEcCtD
Carbamazepine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00339	0.00461	CcSEcCtD
Carbamazepine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00336	0.00457	CcSEcCtD
Carbamazepine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00455	CcSEcCtD
Carbamazepine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00452	CcSEcCtD
Carbamazepine—Promazine—CHRM3—nephrolithiasis	0.00332	0.17	CrCbGaD
Carbamazepine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00444	CcSEcCtD
Carbamazepine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00324	0.00441	CcSEcCtD
Carbamazepine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0032	0.00435	CcSEcCtD
Carbamazepine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00318	0.00433	CcSEcCtD
Carbamazepine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00316	0.0043	CcSEcCtD
Carbamazepine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00423	CcSEcCtD
Carbamazepine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00422	CcSEcCtD
Carbamazepine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00421	CcSEcCtD
Carbamazepine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00414	CcSEcCtD
Carbamazepine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00295	0.00401	CcSEcCtD
Carbamazepine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00295	0.00401	CcSEcCtD
Carbamazepine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00295	0.00401	CcSEcCtD
Carbamazepine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00294	0.00399	CcSEcCtD
Carbamazepine—Imipramine—CHRM3—nephrolithiasis	0.00291	0.148	CrCbGaD
Carbamazepine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00288	0.00392	CcSEcCtD
Carbamazepine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00387	CcSEcCtD
Carbamazepine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00384	CcSEcCtD
Carbamazepine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00384	CcSEcCtD
Carbamazepine—CYP3A4—renal system—nephrolithiasis	0.00279	0.0114	CbGeAlD
Carbamazepine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00278	0.00378	CcSEcCtD
Carbamazepine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00277	0.00376	CcSEcCtD
Carbamazepine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00276	0.00375	CcSEcCtD
Carbamazepine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00371	CcSEcCtD
Carbamazepine—CYP3A4—kidney—nephrolithiasis	0.0027	0.011	CbGeAlD
Carbamazepine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00366	CcSEcCtD
Carbamazepine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00359	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00258	0.0035	CcSEcCtD
Carbamazepine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00347	CcSEcCtD
Carbamazepine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00254	0.00345	CcSEcCtD
Carbamazepine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00252	0.00342	CcSEcCtD
Carbamazepine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00341	CcSEcCtD
Carbamazepine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00338	CcSEcCtD
Carbamazepine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00334	CcSEcCtD
Carbamazepine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00244	0.00331	CcSEcCtD
Carbamazepine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00242	0.00328	CcSEcCtD
Carbamazepine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00242	0.00328	CcSEcCtD
Carbamazepine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00233	0.00317	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00231	0.00314	CcSEcCtD
Carbamazepine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00305	CcSEcCtD
Carbamazepine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00304	CcSEcCtD
Carbamazepine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00304	CcSEcCtD
Carbamazepine—ABCB1—nephron tubule—nephrolithiasis	0.00217	0.00888	CbGeAlD
Carbamazepine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00208	0.00283	CcSEcCtD
Carbamazepine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00276	CcSEcCtD
Carbamazepine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.002	0.00272	CcSEcCtD
Carbamazepine—ABCB1—renal system—nephrolithiasis	0.00197	0.00807	CbGeAlD
Carbamazepine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00193	0.00263	CcSEcCtD
Carbamazepine—ABCB1—kidney—nephrolithiasis	0.00191	0.0078	CbGeAlD
Carbamazepine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00187	0.00254	CcSEcCtD
Carbamazepine—ABCB1—cortex of kidney—nephrolithiasis	0.00186	0.0076	CbGeAlD
Carbamazepine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00244	CcSEcCtD
Carbamazepine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00178	0.00242	CcSEcCtD
Carbamazepine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00178	0.00242	CcSEcCtD
Carbamazepine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00177	0.00241	CcSEcCtD
Carbamazepine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00228	CcSEcCtD
